Evogene Ltd (EVGN):企業の財務・戦略的SWOT分析

◆英語タイトル:Evogene Ltd (EVGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61756FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evogene Ltd (Evogene), a subsidiary of Compugen Ltd, is a biotechnology company that offers plant genomic services. The company offers solutions for crop production improvement through breeding. It develops biotechnology and advanced breeding improved traits for crops that feed the world, including corn, soybean, cotton, canola, rice and wheat, among others. Evogene develops computational analysis tools that allow processing of immense amounts of public and proprietary data in sophisticated and unconventional ways. The company provides trait programs include improved yield, abiotic stress tolerance, improved nitrogen use efficiency and biotic stress tolerance. It serves its clients across Israel. Evogene is headquartered in Rehovot, Israel.

Evogene Ltd Key Recent Developments

Apr 07,2021: Evogene to Hold Virtual Investor & Analyst Days
Mar 25,2021: Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in Israel
Jan 05,2021: Evogene provides 2020 year-end update for CRISPR-IL consortium
Nov 18,2020: Evogene reports third quarter 2020 financial results c
Jun 03,2020: Evogene to participate in CRISPR-IL Consortium to provide end-to-end artificial intelligence system for genome-editing

This comprehensive SWOT profile of Evogene Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Evogene Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Evogene Ltd – Key Information
Evogene Ltd – Overview
Evogene Ltd – Key Employees
Evogene Ltd – Key Employee Biographies
Evogene Ltd – Key Operational Heads
Evogene Ltd – Major Products and Services
Evogene Ltd – History
Evogene Ltd – Company Statement
Evogene Ltd – Locations And Subsidiaries
Evogene Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Evogene Ltd – Business Description
Evogene Ltd – Corporate Strategy
Evogene Ltd – SWOT Analysis
SWOT Analysis – Overview
Evogene Ltd – Strengths
Evogene Ltd – Weaknesses
Evogene Ltd – Opportunities
Evogene Ltd – Threats
Evogene Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Evogene Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Evogene Ltd, Key Information
Evogene Ltd, Key Ratios
Evogene Ltd, Share Data
Evogene Ltd, Major Products and Services
Evogene Ltd, History
Evogene Ltd, Key Employees
Evogene Ltd, Key Employee Biographies
Evogene Ltd, Key Operational Heads
Evogene Ltd, Other Locations
Evogene Ltd, Subsidiaries
Evogene Ltd, Key Competitors
Evogene Ltd, SWOT Analysis
Evogene Ltd, Ratios based on current share price
Evogene Ltd, Annual Ratios
Evogene Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Evogene Ltd (EVGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sarossa plc:企業の戦略的SWOT分析
    Sarossa plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sime Darby Bhd (SIME)
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Apollo Consolidated Ltd (AOP):企業の財務・戦略的SWOT分析
    Summary Apollo Consolidated Ltd (Apollo) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, copper and nickel mineral deposits. Apollo holds exploration permits in Western Australia and Western Africa. The company …
  • GlycoMimetics Inc (GLYC):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that research, develops and commercializes small molecule drugs. The company’s products comprise rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis o …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • Esab Holdings Ltd:企業の戦略・SWOT・財務分析
    Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Esab Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析
    Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Genextra Spa-製薬・医療分野:企業M&A・提携分析
    Summary Genextra SpA (Genextra) is a pharmaceutical company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, mono therapy and diabetes, INT- 777 for metabolic syndrome; novel HDAC and HSP90 inhibitors for the treatment of cancer; mj …
  • Vista Gold Corp.:企業の戦略・SWOT・財務情報
    Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report Summary Vista Gold Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Evotec AG (EVT)-医療機器分野:企業M&A・提携分析
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • TrialBee AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TrialBee AB (TrialBee) is a provider of innovative software solutions that accelerates clinical trials. The company provides services such as online patient recruitment, online study feasibility, study retention and electronic data capture, among others. It offers cloud based solution which …
  • Genome Institute of Singapore-医療機器分野:企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析
    Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, micr …
  • Wake Forest Innovations-製薬・医療分野:企業M&A・提携分析
    Summary Wake Forest Innovations (Wake Forest), a subsidiary of Wake Forest Baptist Medical Center, is an enterprise that advances the development and commercialization of discoveries; services; and products such as medicines and vaccines, from the Medical Center and Wake Forest University. The compa …
  • Saudi Electricity Co (5110):企業の財務・戦略的SWOT分析
    Saudi Electricity Co (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nationwide Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • X-ELIO Energy SL:電力:M&Aディール及び事業提携情報
    Summary X-ELIO Energy SL (X-ELIO), formerly Gestamp Solar, a subsidiary of Corporacion Gestamp S.L. is an alternative energy company that operates utility scale photovoltaic power plants. The company constructs, designs, installs, develops, and maintains solar photovoltaic plants. Its development, c …
  • Nomura Research Institute Ltd (4307):企業の財務・戦略的SWOT分析
    Nomura Research Institute Ltd (4307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sanofi SA:企業の戦略・SWOT・財務情報
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Randstad Holding nv:企業の戦略・SWOT・財務分析
    Randstad Holding nv - Strategy, SWOT and Corporate Finance Report Summary Randstad Holding nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆